|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV033120153 |
003 |
DE-627 |
005 |
20230623224646.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2013 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.earlhumdev.2013.06.001
|2 doi
|
028 |
5 |
2 |
|a GBVA2013012000013.pica
|
035 |
|
|
|a (DE-627)ELV033120153
|
035 |
|
|
|a (ELSEVIER)S0378-3782(13)00139-4
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Milgrom, Jeannette
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Early communication in preterm infants following intervention in the NICU
|
264 |
|
1 |
|c 2013
|
300 |
|
|
|a 8
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a Despite ongoing improvements in clinical care, preterm infants experience a variety of stressors in the first weeks of life, including necessary medical procedures, which may affect development. Some stress-reduction programmes based in the Neonatal Intensive Care Unit (NICU) have reported a positive impact on development. In particular, trials of the Mother–Infant Transaction Program (MITP) have shown positive short and longer term effects, and are based on training parents to recognise and minimise stress responses in preterm infants.
|
700 |
1 |
|
|a Newnham, Carol
|4 oth
|
700 |
1 |
|
|a Martin, Paul R.
|4 oth
|
700 |
1 |
|
|a Anderson, Peter J.
|4 oth
|
700 |
1 |
|
|a Doyle, Lex W.
|4 oth
|
700 |
1 |
|
|a Hunt, Rod W.
|4 oth
|
700 |
1 |
|
|a Achenbach, Thomas M.
|4 oth
|
700 |
1 |
|
|a Ferretti, Carmel
|4 oth
|
700 |
1 |
|
|a Holt, Christopher J.
|4 oth
|
700 |
1 |
|
|a Inder, Terrie E.
|4 oth
|
700 |
1 |
|
|a Gemmill, Alan W.
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:89
|g year:2013
|g number:9
|g pages:755-762
|g extent:8
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2013.06.001
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 89
|j 2013
|e 9
|h 755-762
|g 8
|
953 |
|
|
|2 045F
|a 610
|